Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus

By Matsui M.   Moriya O.   Abdel-Aziz N.   Matsuura Y.   Miyamura T.   Akatsuka T.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 211-220

Elsevier

Access to resources Recommend Favorite

DNA vaccination for the induction of immune responses against hepatitis C virus proteins

By Inchauspe G.   Major M.E.   Nakano I.   Vitvitski L.   Trepo C.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 853-856

Elsevier

Access to resources Recommend Favorite

Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid

By Matsui M.   Moriya O.   Akatsuka T.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1629-1639

Elsevier

Access to resources Recommend Favorite

Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice

By Mauch C.   Grimm C.   Meckel S.   Wands J.R.   Blum H.E.   Roggendorf M.   Geissler M.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 170-180

Elsevier

Access to resources Recommend Favorite

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

By Arribillaga L.   de Cerio A.L.D.   Sarobe P.   Casares N.   Gorraiz M.   Vales A.   Bruna-Romero O.   Borras-Cuesta F.   Paranhos-Baccala G.   Prieto J.   Ruiz J.   Lasarte J.J.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 202-210

Elsevier

Access to resources Recommend Favorite